NCT00056225

Data

{
  "briefSummary": "The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive decline in persons with Alzheimer's disease.",
  "completionDate": "2007-06",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 340,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00056225",
  "phase": "PHASE3",
  "sponsorId": "national-institute-on-aging-nia",
  "startDate": "2003-01",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)",
  "url": "https://clinicaltrials.gov/study/NCT00056225"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version